The Lithotripsy Laser ecosystem comprises a structured value chain that begins with upstream raw‑material and component sourcing, progresses through midstream technology development and system integration, and culminates in downstream distribution and clinical adoption. Upstream participants provide optical crystals, fiber assemblies, and precision mechanical parts that define the performance envelope of laser generators. Midstream actors—laser technology firms, original equipment manufacturers, and system integrators—transform these inputs into clinically approved lithotripsy platforms, embedding pulse‑control electronics and imaging subsystems. Downstream channels, including regional distributors and after‑sales service networks, convey finished systems to hospitals, urology centers, and ambulatory surgical facilities, where end users generate value by delivering stone‑fragmentation procedures. Value is captured at each stage through component margins, licensing fees, integration contracts, and service agreements.